Literature DB >> 7999965

Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway.

J P Berg1, E Glattre, T Haldorsen, A T Høstmark, I G Bay, A F Johansen, E Jellum.   

Abstract

Epidemiologic studies have shown an association between seafood consumption and risk of thyroid cancer. Fish meals increase the serum concentrations of the longchain fatty acids, eicosapentaenoic acid (20:5,n-3) (EPA) and docosahexaenoic acid (22:6,n-3) (DHA), for days. The hypothesis that serum concentrations of fatty acids may be associated with thyroid cancer risk therefore was tested in a population-based case-control study with 74 cases and 221 matched controls. Seventy-three cases with sera in the Norwegian serum bank (JANUS) were identified in the Norwegian Cancer Registry and matched with three controls, also in JANUS, on age, gender, place of residence, and time of blood sampling. One [corrected] case was matched with two controls. Serum concentrations of 11 longchain fatty acids were determined blindly by gas chromatography for all subjects. Controls were divided into three groups with increasing serum fatty acid concentrations, and odds ratios between cases and controls were estimated relative to the group with lowest serum level by univariate and multivariate analyses. The main finding was a significant inverse relation between the sum of arachidonic acid (20:4,n-6) (AA) and DHA serum concentrations and thyroid cancer risk. The significance of this association was weakened when the analyses were restricted to the papillary type of thyroid carcinoma. It was of the same order of magnitude whether the period between blood sampling and diagnosis was greater than eight years, or eight or less years. High EPA/AA ratio, indicating consumption of fish fat, was not associated significantly with increased thyroid-cancer risk.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999965     DOI: 10.1007/BF01694757

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  28 in total

1.  Estrogen receptor in normal and neoplastic human thyroid tissue.

Authors:  P K Chaudhuri; R Prinz
Journal:  Am J Otolaryngol       Date:  1989 Sep-Oct       Impact factor: 1.808

2.  An epidemiologic study of thyroid cancer in Hawaii.

Authors:  L N Kolonel; J H Hankin; L R Wilkens; F H Fukunaga; M W Hinds
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

3.  Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3',5'-monophosphate formation.

Authors:  A Dugrillon; G Bechtner; W M Uedelhoven; P C Weber; R Gärtner
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

4.  Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: the Tromsø study.

Authors:  K H Bønaa; K S Bjerve; A Nordøy
Journal:  Am J Clin Nutr       Date:  1992-06       Impact factor: 7.045

5.  A population-based case-control study of thyroid cancer.

Authors:  E Ron; R A Kleinerman; J D Boice; V A LiVolsi; J T Flannery; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

6.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

7.  The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area.

Authors:  A Belfiore; G L La Rosa; G Padova; L Sava; O Ippolito; R Vigneri
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

8.  Growth inhibition of human hepatoma cells (HepG2) by polyunsaturated fatty acids. Protection by albumin and vitamin E.

Authors:  A T Høstmark; E Lystad
Journal:  Acta Physiol Scand       Date:  1992-01

9.  Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.

Authors:  E Søyland; J Funk; G Rajka; M Sandberg; P Thune; L Rustad; S Helland; K Middelfart; S Odu; E S Falk
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

10.  The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.

Authors:  H E Krokan; K S Bjerve; E Mørk
Journal:  Biochim Biophys Acta       Date:  1993-05-20
View more
  12 in total

Review 1.  Targeting survival pathways in chronic myeloid leukaemia stem cells.

Authors:  A Sinclair; A L Latif; T L Holyoake
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

2.  Increased risk of thyroid cancer among Norwegian women married to fishery workers--a retrospective cohort study.

Authors:  L Frich; L A Akslen; E Glattre
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells.

Authors:  Yunping Hu; Haiguo Sun; Joseph T O'Flaherty; Iris J Edwards
Journal:  Carcinogenesis       Date:  2012-10-11       Impact factor: 4.944

4.  Thyroid Carcinoma in Japan and the West: Similarities and Differences.

Authors:  Shinobu Nakamura; Hiroyuki Nakamura; Yuji Mizukami
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

5.  Plasma ω-3 and ω-6 fatty acids in thyroid diseases.

Authors:  Xiang Li; Hui Li; Jing Zhao; Qi Dai; Chaoran Huang; Langping Jin; Fan Yang; Fuxue Chen; Ouchen Wang; Ying Gao
Journal:  Oncol Lett       Date:  2018-08-09       Impact factor: 2.967

6.  A nested case-control study of polychlorinated biphenyls, organochlorine pesticides, and thyroid cancer in the Janus Serum Bank cohort.

Authors:  Catherine C Lerro; Rena R Jones; Hilde Langseth; Tom K Grimsrud; Lawrence S Engel; Andreas Sjödin; Hyoyoung Choo-Wosoba; Paul Albert; Mary H Ward
Journal:  Environ Res       Date:  2018-04-23       Impact factor: 6.498

7.  Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study.

Authors:  Raul Zamora-Ros; Sabina Rinaldi; Konstantinos K Tsilidis; Elisabete Weiderpass; Marie-Christine Boutron-Ruault; Agnetha Linn Rostgaard-Hansen; Anne Tjønneland; Françoise Clavel-Chapelon; Sylvie Mesrine; Verena A Katzke; Tilman Kühn; Jana Förster; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Eleni Klinaki; Giovanna Masala; Sabina Sieri; Fulvio Ricceri; Rosario Tumino; Amalia Mattiello; Petra H M Peeters; H B As Bueno-de-Mesquita; Dagrun Engeset; Guri Skeie; Marcial Argüelles; Antonio Agudo; María-José Sánchez; María-Dolores Chirlaque; Aurelio Barricarte; Saioa Chamosa; Martin Almquist; Ada Tosovic; Joakim Hennings; Maria Sandström; Julie A Schmidt; Kay-Thee Khaw; Nicholas J Wareham; Amanda J Cross; Nadia Slimani; Graham Byrnes; Isabelle Romieu; Elio Riboli; Silvia Franceschi
Journal:  Int J Cancer       Date:  2015-07-30       Impact factor: 7.396

8.  A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Authors:  Jeffrey D Altenburg; Andrew A Bieberich; Colin Terry; Kevin A Harvey; Justin F Vanhorn; Zhidong Xu; V Jo Davisson; Rafat A Siddiqui
Journal:  BMC Cancer       Date:  2011-04-21       Impact factor: 4.430

9.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.

Authors:  Rafat A Siddiqui; Mustapha Zerouga; Min Wu; Alicia Castillo; Kevin Harvey; Gary P Zaloga; William Stillwell
Journal:  Breast Cancer Res       Date:  2005-06-07       Impact factor: 6.466

10.  Characterization of synergistic anti-cancer effects of docosahexaenoic acid and curcumin on DMBA-induced mammary tumorigenesis in mice.

Authors:  Rafat A Siddiqui; Kevin A Harvey; Candace Walker; Jeffrey Altenburg; Zhidong Xu; Colin Terry; Ignacio Camarillo; Yava Jones-Hall; Cary Mariash
Journal:  BMC Cancer       Date:  2013-09-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.